Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database

@MichaelLuc26035 @Jjulian6412 @newstart_2024 https://t.co/tBQqlnGnVy https://t.co/6K9nUhYDOU

@Bordonaro_song @randyhillier @VigilantFox @rainnikko1 "Our analysis showed that remdesivir is well tolerated and has an acceptable safety profile. The clinical outcome of cure/improvement was 84%, with a higher improvement in patients < 60 years old an

@KinseyKat1 @DawnsMission yes, and many others "Our analysis showed that remdesivir is well tolerated and has an acceptable safety profile. The clinical outcome of cure/improvement was 84%, with a higher improvement in patients < 60 years old and on st

@ivan_skava65522 @RickHol7 @DiedSuddenly_ "Our analysis showed that remdesivir is well tolerated and has an acceptable safety profile. The clinical outcome of cure/improvement was 84%, with a higher improvement in patients < 60 years old and on standard